PON1 and hepatocellular carcinoma: Some new light on this issue was shed by studies on human hepatocellular carcinoma (HepG2) cell lines treated with methyl parathion and chlorpyriphos, where a significant decrease in PON1 mRNA expression was noted, along with the increased secretion of pro-inflammatory mediators [91,92].